[1] Sensoy N,Dogan N,Ozek B,et al.Urinary incontinence in women: prevalence rates, risk factors and impact on quality of life.Pak J Med Sci.2013;29(3):818-822.
[2] Kwon BE,Kim GY,Son YJ,et al.Quality of life of women with urinary incontinence: a systematic literature review.Int Neurourol J.2010;14(3):133-138.
[3] Ko Y,Lin SJ,Salmon JW,et al.The impact of urinary incontinence on quality of life of the elderly.Am J Manag Care.2005;11(4):103-111.
[4] Hermieu JF,Le Guilchet T.Genital prolapse and urinary incontinence: a review. J Med Liban.2013;61(1):61-66.
[5] Minassian VA,Drutz HP,Al-Badr A.Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet. 2003;82(3): 327-338.
[6] Sergent F,Gay-Crosier G,Resch B,et al.A comparative study between two procedures of TVT retropubic mid-urethral sling placement for treatment of female stress urinary incontinence. J Gynecol Obstet Biol Reprod.2013;2315(13):215-219.
[7] Fan X,Wang Y,Wang Y,et al.Comparison of polypropylene mesh and porcine-derived, cross-linked urinary bladder matrix materials implanted in the rabbit vagina and abdomen. Int Urogynecol J.2014;25(5):683-689.
[8] Jensen KK,Rashid L,Pilsgaard B,et al.Pelvic floor reconstruction with a biological mesh after extralevator abdominoperineal excision leads to few perineal hernias and acceptable wound complication rates with minor movement limitations: single-centre experience including clinical examination and interview.Colorectal Dis. 2014;16(3): 192-197.
[9] Rice NT,Hu Y,Slaughter JC,et al. Pelvic mesh complications in women before and after the 2011 FDA public health notification.Female Pelvic Med Reconstr Surg. 2013;19(6): 333-338.
[10] Rickey LM,Huang L,Rahn DD,et al.Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery.Adv Urol.2013;2013(7):1-8.
[11] Wu MP,Huang KH,Long CY,et al.In vitro extracellular matrix model to evaluate stroma cell response to transvaginal mesh. Neurourol Urodyn.2013;66(3):488-492.
[12] Badylak SF.The extracellular matrix as a biologic scaffold material. Biomaterials. 2007;28(25):3587-3593.
[13] Badylak SF.Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.Transpl Immunol.2004;12(3-4): 367-377.
[14] Campoccia D,Montanaro L,Arciola CR.A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials.2013;34(34):8533-8554.
[15] Campoccia D,Montanaro L,Arciola CR.A review of the clinical implications of anti-infective biomaterials and infection- resistant surfaces.Biomaterials.2013; 34(33):8018-8029.
[16] Alvarez J,Cvach K,Dwyer P.Complications in pelvic floor surgery. Minerva Ginecol. 2013;65(1):53-67.
[17] Moore T,Tubman I,Levy G,et al.Age as a risk factor for perioperative complications in women undergoing pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2010;16(5):290-295.
[18] 何伟,王翔,高莹,等.新型纳米银/聚氨酯胆道支架表面抗菌涂层的体外抑菌试验[J].中国组织工程研究与临床康复,2011,15(3): 453-456.
[19] Kova?evi? J, Mesak LR,Allen KJ. Occurrence and characterization of Listeria spp. in ready-to-eat retail foods from Vancouver, British Columbia. Food Microbiol.2012; 30(2):372-378.
[20] 姜双应.四种抗菌产品抑菌作用的实验室观察[J].中国消毒学杂志,2008,25(3):255-257.
[21] Zhang H,Tang J,Meng X,et al.Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol.Dig Dis Sci.2005; 50(6):1046-1051.
[22] Li D,Xiao XR,Zhu Z,et al.Study the inhibitory effects of three oral actinomyces on growth of oral Candida albicans in vitro.Hua Xi Kou Qiang Yi Xue Za Zhi.2008; 26(5):553-555.
[23] Zhou B,Hu Y,Li J,et al.Chitosan/phosvitin antibacterial films fabricated via layer-by-layer deposition.Int J Biol Macromol. 2014;64:402-408.
[24] 董炎明.壳聚糖衍生物的红外光谱分析[J].纤维素科学与技术, 2001,9(2):42-54.
[25] Mahjub R,Dorkoosh FA,Amini M,et al.In vitro characterization and cell cytotoxicity of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.J Control Release. 2013;172(1):112-118.
[26] Amaral IF,Granja PL,Barbosa MA.Chemical modification of chitosan by phosphorylation: an XPS, FT-IR and SEM study.J Biomater Sci Polym Ed.2005;16(12): 1575-1593.
[27] 李立华,李红,罗丙红,等.壳聚糖及其衍生物在组织工程中的应用[J].功能高分子学报,2005,18(2):347-352.
[28] Helström L,Nilsson B.Impact of vaginal surgery on sexuality and quality of life in women with urinary incontinence or genital descensus.Acta Obstet Gynecol Scand. 2005;84(1): 79-84.
[29] Benhaim Y,de Tayrac R,Deffieux X,et al.Treatment of genital prolapse with a polypropylene mesh inserted via the vaginal route. Anatomic and functional outcome in women aged less than 50 years.J Gynecol Obstet Biol Reprod. 2006;35(3): 219-226.
[30] Capobianco G,Donolo E,Wenger JM,et al.Efficacy and 9 years' follow-up of posterior intravaginal slingplasty for genital prolapse.J Obstet Gynaecol Res.2014;40(1):219-223.
[31] Ulukent SC,Kaya B,Bat O,et al.Prolene mesh migration into the rectum after sacral colpopexy presented with frozen pelvis.Int J Surg Case Rep.2013;4(11):1004-1006.
[32] Thomin A,Touboul C,Hequet D,et al.Genital prolapse repair with Avaulta Plus mesh: functional results and quality of life.Prog Urol.2013;23(4):270-275.
[33] Freytes DO,Tullius RS,Badylak SF.Effect of storage upon material properties of lyophilized porcine extracellular matrix derived from the urinary bladder.J Biomed Mater Res B Appl Biomater.2006;78(2):327-333.
[34] Turner NJ,Yates AJ Jr,Weber DJ,et al.Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. Tissue Eng Part A.2010;16(11):3309-3317.
[35] Liu L,Li D,Wang Y,et al.Evaluation of the biocompatibility and mechanical properties of xenogeneic (porcine) extracellular matrix (ECM) scaffold for pelvic reconstruction.Int Urogynecol J.2011;22(2):221-227.
[36] Huber JE,Spievack A,Simmons-Byrd A,et al.Extracellular matrix as a scaffold for laryngeal reconstruction.Ann Otol Rhinol Laryngol.2003;112(5):428-333.
[37] Badylak SF.The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol.2002;13(5):377-383.
[38] Badylak SF,Gilbert TW.Immune response to biologic scaffold materials. Semin Immunol.2008;20(2):109-116.
[39] Khalili H,Dashti-Khavidaki S,Khaleghi S,et al.Evaluation of tigecycline activity against methicillin-resistante staphylococcus aureus isolated from Biological Samples.Iran J Pharm Res.2010;9(1):61-65.
[40] Swoboda S,Ober M,Hainer C,et al.Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.J Antimicrob Chemother.2008;61(3):729-733.
[41] Blot S,De Waele JJ,Vogelaers D.Essentials for selecting antimicrobial therapy for intra-abdominal infections.Drugs. 2012;72(6):17-32. |